729 related articles for article (PubMed ID: 19446319)
21. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer.
Cragun JM; Havrilesky LJ; Calingaert B; Synan I; Secord AA; Soper JT; Clarke-Pearson DL; Berchuck A
J Clin Oncol; 2005 Jun; 23(16):3668-75. PubMed ID: 15738538
[TBL] [Abstract][Full Text] [Related]
22. Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer.
Akbayır O; Corbacıoglu Esmer A; Numanoglu C; Cılesız Goksedef BP; Akca A; Bakır LV; Kuru O
Arch Gynecol Obstet; 2012 Nov; 286(5):1269-76. PubMed ID: 22729137
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: a multi-institutional analysis of 608 women.
Macdonald OK; Sause WT; Lee RJ; Lee CM; Dodson MK; Zempolich K; Gaffney DK
Gynecol Oncol; 2006 Nov; 103(2):661-6. PubMed ID: 16797682
[TBL] [Abstract][Full Text] [Related]
24. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
Fujimoto T; Nanjyo H; Nakamura A; Yokoyama Y; Takano T; Shoji T; Nakahara K; Yamada H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
Gynecol Oncol; 2007 Nov; 107(2):253-9. PubMed ID: 17640720
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer.
Aoki Y; Watanabe M; Amikura T; Obata H; Sekine M; Yahata T; Fujita K; Tanaka K
Gynecol Oncol; 2004 Aug; 94(2):333-9. PubMed ID: 15297170
[TBL] [Abstract][Full Text] [Related]
26. Analysis of failures in patients with FIGO stage IIIc1-IIIc2 endometrial cancer.
Gadducci A; Cosio S; Fabrini MG; Guerrieri ME; Greco C; Genazzani AR
Anticancer Res; 2012 Jan; 32(1):201-5. PubMed ID: 22213308
[TBL] [Abstract][Full Text] [Related]
27. Surgical stage, final grade, and survival of women with endometrial carcinoma whose preoperative endometrial biopsy shows well-differentiated tumors.
Eltabbakh GH; Shamonki J; Mount SL
Gynecol Oncol; 2005 Nov; 99(2):309-12. PubMed ID: 16005945
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer.
Zusterzeel PL; Bekkers RL; Hendriks JC; Neesham DN; Rome RM; Quinn MA
Acta Obstet Gynecol Scand; 2008; 87(2):240-6. PubMed ID: 18231895
[TBL] [Abstract][Full Text] [Related]
29. Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: a retrospective study.
Sovak MA; Hensley ML; Dupont J; Ishill N; Alektiar KM; Abu-Rustum N; Barakat R; Chi DS; Sabbatini P; Spriggs DR; Aghajanian C
Gynecol Oncol; 2006 Nov; 103(2):451-7. PubMed ID: 16677690
[TBL] [Abstract][Full Text] [Related]
30. Nodal distribution and its significance in FIGO stage IIIc endometrial cancer.
McMeekin DS; Lashbrook D; Gold M; Scribner DR; Kamelle S; Tillmanns TD; Mannel R
Gynecol Oncol; 2001 Aug; 82(2):375-9. PubMed ID: 11531298
[TBL] [Abstract][Full Text] [Related]
31. High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy.
Mariani A; Dowdy SC; Keeney GL; Long HJ; Lesnick TG; Podratz KC
Gynecol Oncol; 2004 Oct; 95(1):120-6. PubMed ID: 15385120
[TBL] [Abstract][Full Text] [Related]
32. Outcome of endometrial carcinoma patients with involvement of the uterine serosa.
Ashman JB; Connell PP; Yamada D; Rotmensch J; Waggoner SE; Mundt AJ
Gynecol Oncol; 2001 Aug; 82(2):338-43. PubMed ID: 11531290
[TBL] [Abstract][Full Text] [Related]
33. Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study.
Sutton G; Axelrod JH; Bundy BN; Roy T; Homesley HD; Malfetano JH; Mychalczak BR; King ME
Gynecol Oncol; 2005 Jun; 97(3):755-63. PubMed ID: 15913742
[TBL] [Abstract][Full Text] [Related]
34. Routine pelvic lymphadenectomy in apparently early stage endometrial cancer.
Zuurendonk LD; Smit RA; Mol BW; Feijen HW; de Graaff J; Sykora D; de Winter KA; vd Wurff A; Snijders MP; Kruitwagen RF
Eur J Surg Oncol; 2006 May; 32(4):450-4. PubMed ID: 16546343
[TBL] [Abstract][Full Text] [Related]
35. Positive adnexal or uterine serosal involvement in stage IIIC endometrial cancer is an adverse factor for recurrence.
Hétu V; Petignat P; Wu Y; Drouin P; Sauthier P; Provencher D; Gauthier P
Gynecol Obstet Invest; 2009; 67(3):173-7. PubMed ID: 19088481
[TBL] [Abstract][Full Text] [Related]
36. Uterine papillary serous carcinoma: patterns of failure and survival.
Wang W; DO V; Hogg R; Wain G; Brand A; Bull C; Stenlake A; Gebski V
Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700
[TBL] [Abstract][Full Text] [Related]
37. Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome.
Denschlag D; Tan L; Patel S; Kerim-Dikeni A; Souhami L; Gilbert L
Am J Obstet Gynecol; 2007 Jun; 196(6):546.e1-7. PubMed ID: 17547889
[TBL] [Abstract][Full Text] [Related]
38. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.
Susumu N; Sagae S; Udagawa Y; Niwa K; Kuramoto H; Satoh S; Kudo R;
Gynecol Oncol; 2008 Jan; 108(1):226-33. PubMed ID: 17996926
[TBL] [Abstract][Full Text] [Related]
39. Is endometrial carcinoma intrinsically more aggressive in elderly patients?
Alektiar KM; Venkatraman E; Abu-Rustum N; Barakat RR
Cancer; 2003 Dec; 98(11):2368-77. PubMed ID: 14635071
[TBL] [Abstract][Full Text] [Related]
40. Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy.
Kuoppala T; Mäenpää J; Tomas E; Puistola U; Salmi T; Grenman S; Lehtovirta P; Fors M; Luukkaala T; Sipilä P
Gynecol Oncol; 2008 Aug; 110(2):190-5. PubMed ID: 18534669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
